Stellantis Vehicles Are Piling Up at Car Dealerships

WSJ What’s News

The Wall Street Journal

Daily News, News

4.1 • 4.2K Ratings

🗓️ 24 May 2024

⏱️ 14 minutes

🔗️ Recording | iTunes | RSS

🧾️ Download transcript

Summary

P.M. Edition for May 24. A group of Jeep and Ram brand dealers recently vented their frustration to Stellantis executives about high sticker prices keeping buyers at bay. Ryan Felton has more. And Eli Lilly makes the biggest investment in its history to ramp up production of its hot-selling weight-loss drugs. Peter Loftus reports. Plus, the U.N.’s International Court of Justice orders Israel to halt some military operations in Gaza. Pierre Bienaimé hosts. Sign up for the WSJ's free What's News newsletter. Learn more about your ad choices. Visit megaphone.fm/adchoices

Transcript

Click on a timestamp to play from that location

0:00.0	There's diggin and then there's super digging. There's food and then there's Baker's Superfoods made with selected natural ingredients and tasty chicken.
0:15.8	The food.
0:16.8	And then there's Baker Superfoods.
0:19.8	Eli Lillie. Eli Lilly announces the biggest manufacturing investment in its history
0:28.4	and Automaker Stellantis is getting some backlash from car dealerships.
0:33.4	Their dealers in the US have more unsold cars sitting on their lots for longer periods of time
0:38.9	than their competitors in the industry.
0:40.7	Plus the UN's International Court of Justice orders Israel to
0:44.4	halt some military operations. It's Friday, May 24th. I'm Caribbean for the
0:49.8	Wall Street Journal. This is the PM edition of What's News, the top headlines and
0:54.0	business stories that moved the world today.
1:01.0	Eli Lillie
1:01.5	plans to spend 5.3 billion dollars to boost manufacturing capacity of its
1:06.4	anti-obesity drug Zeppbound and the diabetes drug Mount
1:09.3	Mount Jaro. The company said it will expand a production under construction 30 miles from its Indianapolis headquarters.
1:15.8	Faced with shortages of these popular drugs,
1:18.2	Lily will be spending $9 billion in total on the new site.
1:21.5	That's the biggest manufacturing investment in its history.
1:24.6	Peter Loft just covers the pharmaceutical industry for the Wall Street Journal.
1:28.0	Peter, why is Eli Lillie making this investment now? Well Eli Lillie is making this investment now? Well Eli Lilly is making this investment now because they've
1:34.7	realized that they just can't make enough of these drugs to meet what the demand is.
1:40.7	The demand for Zeppbound and Moundaro and even other similar drugs like Ozempik has just skyrocketed over the last few years.
	...

Please login to see the full transcript.

Previous episode | Next episode

Disclaimer: The podcast and artwork embedded on this page are from The Wall Street Journal, and are the property of its owner and not affiliated with or endorsed by Tapesearch.

Generated transcripts are the property of The Wall Street Journal and are distributed freely under the Fair Use doctrine. Transcripts generated by Tapesearch are not guaranteed to be accurate.